To summarise, we have shown that sFRP1 represses AR transcriptional activity and, as a result, inhibits proliferation of androgen-dependent prostate cancer cells and that the CRD is mainly responsible for both of these effects. This evidence concerns the gene SFRP1 and prostate cancer.